Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Immunoglobulin Light-chain Amyloidosis × Bortezomib × Clear all

Phase

Phase 2 10 Phase 3 6 Phase NA 3 Phase 1 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 7 Waldenstrom Macroglobulinemia 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Neoplasms 1 Neoplasm, Residual 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Neoplasms 1

Interventions

Thalidomide 1 Cyclophosphamide 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Guangdong Provincial People's Hospital

Phase 4 Unknown

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡